Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion type Assertion NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_head.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion description "[Collectively, these findings show that GBM therapeutic resistance to EGFR inhibitors may be explained by compensatory activation of EGFR-related family members (ERBB2, ERBB3) enabling GBM CSC proliferation, and therefore simultaneous blockade of multiple ERBB family members may be required for more efficacious GBM therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_provenance.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion evidence source_evidence_literature NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_provenance.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion SIO_000772 22745588 NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_provenance.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion wasDerivedFrom befree-20150227 NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_provenance.
- NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_assertion wasGeneratedBy ECO_0000203 NP380698.RAwiypf5pB0pdhjWUSUfFeD6dS-C11aZ0uYos8O920wqk130_provenance.